| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/27/2013 | CN102988404A Astragalus polysaccharide injection and preparation method thereof |
| 03/27/2013 | CN102988403A Injection medicine composition used for treating facial paralysis in acute stage |
| 03/27/2013 | CN102988402A Pharmaceutical composition containing adenosine cyclophosphate compound and preparation method of pharmaceutical composition |
| 03/27/2013 | CN102988401A Application of adenosine triphosphate or medicinal salt of adenosine triphosphatein in preparation of medicine for treating endometriosis |
| 03/27/2013 | CN102988400A Application of liquiritin in preparing escherichia coli fluoroquinolone efflux pump inhibitor |
| 03/27/2013 | CN102988399A Medicine composition and application and preparation thereof |
| 03/27/2013 | CN102988398A Traditional Chinese medicine composition mixture for treating ischemic cerebrovascular disease and preparation method thereof |
| 03/27/2013 | CN102988397A Application of Houttuynoid A for preparing monoamine oxidase (MAO) inhibitor medicine |
| 03/27/2013 | CN102988396A Application of Houttuynoid D in preparation of monoamine oxidase (MAO) inhibitor |
| 03/27/2013 | CN102988395A Application of Houttuynoid E in preparation of medicine for promoting insulin secretion |
| 03/27/2013 | CN102988394A Application of Houttuynoid D in preparation of medicine for treating acute gout |
| 03/27/2013 | CN102988393A Application of Houttuynoid B for preparing medicine for treating rhinitis |
| 03/27/2013 | CN102988392A Application of Houttuynoid B to preparation of medicine for rising red blood cells |
| 03/27/2013 | CN102988391A Application of Houttuynoid E to preparation of medicine for treating osteoporosis caused by lack of antiestrogen |
| 03/27/2013 | CN102988390A Application of Houttuynoid C for preparing medicine for treating rhinitis |
| 03/27/2013 | CN102988389A Application of Houttuynoid B for preparing aseptic inflammation resistant medicine |
| 03/27/2013 | CN102988388A Application of Houttuynoid B to preparation of medicine for rising platelets |
| 03/27/2013 | CN102988387A Application of Houttuynoid D to preparation of medicine for rising platelets |
| 03/27/2013 | CN102988386A Application of Houttuynoid E in preparation of medicine for reducing blood sugar |
| 03/27/2013 | CN102988385A Application of Houttuynoid A to preparation of medicine for treating osteoporosis caused by lack of antiestrogen |
| 03/27/2013 | CN102988384A Application of Houttuynoid C for preparing medicine for treating acute gout |
| 03/27/2013 | CN102988383A Application of Houttuynoid E in preparation of medicine for treating chronic obstructive pulmonary disease |
| 03/27/2013 | CN102988382A Application of Houttuynoid C for preparing medicine for treating or preventing dental ulcer |
| 03/27/2013 | CN102988381A Application of Houttuynoid A for preparing medicine for promoting insulin to secrete |
| 03/27/2013 | CN102988380A Application of Houttuynoid B to preparation of medicine for rising white blood cells |
| 03/27/2013 | CN102988379A Application of Houttuynoid C for preparing aseptic inflammation resistant medicine |
| 03/27/2013 | CN102988378A Application of Houttuynoid C in preparation of medicine for treating rheumatoid arthritis |
| 03/27/2013 | CN102988377A Application of Houttuynoid D in preparation of medicine for treating chronic obstructive pulmonary disease |
| 03/27/2013 | CN102988376A Fishery medicine of eucalyptus oil abamectin sub-microemulsion |
| 03/27/2013 | CN102988375A Application of breviscapine in hepatic stellate cell migration inhibition drug preparation |
| 03/27/2013 | CN102988374A Poly-lactic-co-glycolic acid-polylysine-polyethylene glycol-tetrandrine and daunorubicin copolymer nanoparticles as well as preparation method and application thereof |
| 03/27/2013 | CN102988373A Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 03/27/2013 | CN102988372A Screening and composition of main auxiliary materials of compound aspirin tablet, and preparation method of compound aspirin sheet |
| 03/27/2013 | CN102988371A Kidney-warming and cold-dissipating tablet |
| 03/27/2013 | CN102988370A Application of tanshinone I in preparation of medicine for treating psoriasis |
| 03/27/2013 | CN102988369A Application of compound pachymic acid in preparing medicines |
| 03/27/2013 | CN102988368A High-purity texaphyrin metal complex |
| 03/27/2013 | CN102988367A Application of tetrandrine in hepatic stellate cell migration inhibition drug preparation |
| 03/27/2013 | CN102988366A Use and nasal administration medicine of hydroxycamptothecine |
| 03/27/2013 | CN102988365A Dose forms comprising VX-950 and their dosage regimen |
| 03/27/2013 | CN102988364A Pharmaceutical composition containing valsartan and amlodipine besylate and preparation method |
| 03/27/2013 | CN102988363A Medicine for treating poultry proventriculitis and necrotic enteritis and preparation method thereof |
| 03/27/2013 | CN102988362A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 03/27/2013 | CN102988361A Resveratrol and temozolomide double-medicine-loaded nanospheres, as well as application and preparation method thereof |
| 03/27/2013 | CN102988360A Compound amino acid injection (15HBC) composition |
| 03/27/2013 | CN102988359A Compound amino acid injection (18AA-I) composition |
| 03/27/2013 | CN102988358A Compound amino acid injection (18AA-IV) composition |
| 03/27/2013 | CN102988357A Compound alpha keto acid medicine composition and preparation method thereof |
| 03/27/2013 | CN102988356A Medicine composition with carbazole alkaloid in clausena plants as antineoplastic activity ingredient and preparation method and application thereof |
| 03/27/2013 | CN102988355A Application of Aphanamixoid A for preparing helicobacter pylori resistant medicine |
| 03/27/2013 | CN102988354A Application of Aphanamixoid A for preparing vascular dilation medicine |
| 03/27/2013 | CN102988353A Application of Aphanamixoid A for preparing medicine for treating ischemic brain injury |
| 03/27/2013 | CN102988352A Application of Aphanamixoid A in medicine for treating dengue virus infection |
| 03/27/2013 | CN102988351A Application of Aphanamixoid A for preparing medicine for treating myocardial ischemia |
| 03/27/2013 | CN102988350A Application of Aphanamixoid A in influenza A virus (Flu-A) resistant medicine |
| 03/27/2013 | CN102988349A Application of Aphanamixoid A for preparing platelet aggregation resistant medicine |
| 03/27/2013 | CN102988348A Application of Aphanamixoid A for preparing anti-hypoxic medicine |
| 03/27/2013 | CN102988347A Application of Aphanamixoid A for preparing medicine for treating or preventing chronic heart failure |
| 03/27/2013 | CN102988346A Application of Aphanamixoid A in respiratory syncytial virus (RSV) resistant medicine |
| 03/27/2013 | CN102988345A Application of Aphanamixoid A for preparing human fungal resistant medicine |
| 03/27/2013 | CN102988344A Application of Aphanamixoid A for preparing medicine for treating or preventing acute heart failure |
| 03/27/2013 | CN102988343A Application of artesunate in preparation of medicine used for inhibiting migration of hepatic stellate cells |
| 03/27/2013 | CN102988342A Application of cyclo-icaritin aglycone in preparation of anti-inflammatory and antimicrobial medicaments |
| 03/27/2013 | CN102988341A Tissue specificity proteasome inhibitor and application thereof |
| 03/27/2013 | CN102988340A Application of salvianolic acid B salt in preparing medicament for inhibiting hepatic stellate cell migration |
| 03/27/2013 | CN102988339A Preparation method and application of fenofibrate nano-crystal powder |
| 03/27/2013 | CN102988338A Nitrate esters and their use for the treatment of muscle and muscle related diseases |
| 03/27/2013 | CN102988337A Histone deacetylase inhibitor and application thereof |
| 03/27/2013 | CN102988336A Use of TPCK (N-tosyl-L-phenylanyl chloromethyl ketone) in preparation of anti-lenticular opacity products |
| 03/27/2013 | CN102988335A Antifungal composition |
| 03/27/2013 | CN102988334A Application of 2-methoxy-6-acetyl-7-methyljuglone (MAM) for preparing medicine for treating neoplastic diseases |
| 03/27/2013 | CN102988333A Medical application of cardamonin |
| 03/27/2013 | CN102988332A Application of compound in preparation of antibacterial medicaments |
| 03/27/2013 | CN102988331A Use of 2-mercapto-3-butanol in preparation of anti-lenticular opacity products |
| 03/27/2013 | CN102988330A Novel nutraceuticalcompositions containing thymol and/or p-cymene or plant extracts for cognition |
| 03/27/2013 | CN102988328A Method for preparing oral medicine for curing cancer, oral medicine for curing cancer and application thereof |
| 03/27/2013 | CN102988327A Mangiferin capsule and preparation method thereof |
| 03/27/2013 | CN102988326A Febuxostat tablets and preparation method and detection method thereof |
| 03/27/2013 | CN102988325A Preparation method of manidipine sustained release tablet |
| 03/27/2013 | CN102988324A Preparation for glipizide compression-coated controlled-release tablets |
| 03/27/2013 | CN102988323A Preparation method of aniracetam sustained-release tablet |
| 03/27/2013 | CN102988322A Arginine ibuprofen tablet and preparation method thereof |
| 03/27/2013 | CN102988321A Clopidogrel hydrogen sulfate tablets and production method thereof |
| 03/27/2013 | CN102988320A Capecitabine dispersible tablet and preparation method thereof |
| 03/27/2013 | CN102988319A III crystal form pramipexole hydrochloride tablet and preparation method thereof |
| 03/27/2013 | CN102988318A Orally rapidly disintegrating tablet and process for producing same |
| 03/27/2013 | CN102988317A Amlodipine besylate medicinal preparation and preparation method thereof |
| 03/27/2013 | CN102988316A Efavirenz tablet and preparation method thereof |
| 03/27/2013 | CN102988315A Preparation method of agomelatine solid preparation |
| 03/27/2013 | CN102988314A Lelrozol orally-disintegrating tablet and its preparation method |
| 03/27/2013 | CN102988313A Anastrozole dispersible tablet and preparation method thereof |
| 03/27/2013 | CN102988312A Clopidogrel hydrogen sulfate tablets and preparation method thereof |
| 03/27/2013 | CN102988311A Thrombolytic freeze-dried powder injection and preparation method thereof |
| 03/27/2013 | CN102988310A Application of salvianolic acid A lyophilized powder in preparation of medicine for protecting ischemia brain tissue |
| 03/27/2013 | CN102988309A Application of salvianolic acid A lyophilized powder in preparation of medicine for inhibiting brain tissueneuron damage or death |
| 03/27/2013 | CN102988308A Application of salvianolic acid A lyophilized powder in preparation of medicine for protecting cerebrovascular endothelial cells |
| 03/27/2013 | CN102988307A Salvianolic acid freeze-dried powder injection and application of preparing medicines thereof |
| 03/27/2013 | CN102988306A Medicinal composition containing sodium ozagrel compound |
| 03/27/2013 | CN102988305A Medicinal composition containing meglumine cyclic adenosine monophosphate compound |
| 03/27/2013 | CN102988304A Medicinal composition containing lysine hydrochloride compound |